openPR Logo
Press release

Opus Energy sets new £10,000 charity challenge for employees

06-23-2010 02:01 PM CET | Energy & Environment

Press release from: Opus Energy

/ PR Agency: FD
Opus Energy supports the CF Trust

Opus Energy supports the CF Trust

Opus Energy, one of the UK’s leading business energy suppliers, has pledged to raise £10,000 throughout 2010/11, for one of the UK's most common, life-threatening, inherited diseases, Cystic Fibrosis.

Over the next year the employees of the Northamptonshire based energy company will embark on a calendar of fundraising and volunteering activities in and around the community. They will organise fun days in the office, take part in individual and team events, make personal donations and take part in some of the challenges organised by the charity.

By pledging to raise £10,000 the energy supplier will be helping sufferers in and around Northamptonshire receive the daily treatment they need.

Charlie Crossley Cooke, founder and Managing Director of Opus Energy comments;

“The Cystic Fibrosis Trust is a charity that is very close to the heart of an Opus employee who has a young child living with the disease. Due to the comparatively low numbers of people suffering from Cystic Fibrosis it is often overlooked but, because of our personal exposure, the need to assist the charity with the invaluable work they do really has really struck a chord. Opus will be donating the money to help provide support and care for those affected in the Northamptonshire area and also to help raise awareness of the disease.”

The Cystic Fibrosis trust is the UK's only national charity dealing with all aspects of the disease. The fundraisers and Expert Patient Advisors throughout the UK, fund research to treat and cure the disease and aim to ensure appropriate clinical care and support for people suffering.

Sue Piper, Senior Corporate and Trust Fundraising Manager for Cystic Fibrosis comments;

“We are absolutely delighted that Opus Energy has chosen us as their charity of the year.

“The disease claims so many young lives. The money raised will help to fund treatment and equipment that Cystic Fibrosis sufferers in Northamptonshire need, as well as raise awareness in the area. It will also help us to provide information, support and the necessary treatment to families in Northamptonshire and ensure that young people get the appropriate clinical care.

“We very much look forward to engaging Opus employees in lots of fundraising opportunities, events and campaigns throughout the year to ensure they put the 'fun' into fundraising.”

Over the past two years, Opus employees have held a number of fundraising activities to succeed in raising over £20,000 for the Friends of Cynthia Spencer Hospice and the NSPCC.


Notes to editors
For more information on Opus Energy’s pledge to the Cystic Fibrosis Trust and Opus Energy’s community lead fundraising initiatives, visit

About Opus Energy
Opus Energy is a leading independent supplier of electricity and gas to UK businesses. With offices in Northampton and Oxford, Opus Energy employs over 230 people.

Opus Energy supplies over 60,000 UK business sites across all sectors. Large customers include: Stagecoach, Thorntons, Farmfoods, FirstGroup, and John Lewis.

Opus Energy’s management team has a 50 per cent stake in the business, while International Power Plc (LSE:IPR.L) holds 30 per cent and Telecom Plus Plc (LSE: TEP.L ) has 20 per cent.

For further information about Opus Energy, please see

About Cystic Fibrosis
Cystic Fibrosis affects the internal organs, especially the lungs and digestive system, by clogging them with thick sticky mucus, making it hard to breathe and digest food. There are over 8,500 people in the UK with it and over 2 million carrying the faulty gene that causes the disease; that’s around 1 in 25 of the population. This means if two carriers have a child, the baby has a 1 in 4 chance of having Cystic Fibrosis.*

* SOURCE: Cystic Fibrosis Trust

Opus Energy
Opus House
285 Banbury Road

For press enquiries, please contact
Leo Wood / Nicole Sharp
T. 0207 269 7137 / 7258
E. /

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opus Energy sets new £10,000 charity challenge for employees here

News-ID: 136171 • Views:

More Releases for Cystic

Cystic Fibrosis Market Report-Growth with Industry Study, Detailed Analysis | Cy …
The research study contains an in detail descriptive overview and analysis of the Cystic Fibrosis Market, a summary of the market shares constituted by each component, the annual growth of each sector, and the revenue potential of the section. In addition, Cystic Fibrosis Market production and consumption data are used to determine the geographical features. Get FREE PDF sample of the Report @ Top Company Profile Analysis in this Report- Cystic Fibrosis
The Cystic Fibrosis Market to Witness Robust Growth Due to Increasing Cases of C …
Cystic fibrosis is a rare, progressive, life-threatening disease results in the formation of thick mucus that builds up in the lungs, digestive tract, and other parts of the body. If left untreated, it leads to severe digestive and respiratory problems as well as other complications such as infections and diabetes. According to the Cystic Fibrosis Foundation, more than 70,000 people are living with cystic fibrosis around the world. As the
Cystic Fibrosis Therapeutics Market - Forecasts to 2026
As per the research conducted by GME, the Global Cystic Fibrosis Therapeutics Market will grow with a CAGR value of 13.5% by 2026. Cystic fibrosis is becoming more prevalent, resulting in increased awareness, technological improvements, strong pipeline prospects, and expanding R&D initiatives which are some of the factors to influence the growth of the market. The disease has no permanent cure but the symptoms and complications can be reduced by
Cystic Fibrosis Market Opportunity Analysis, 2018-2026
Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF. Some of the other signs and symptoms include sinus infections, poor growth, infertility in males, fatty stool, and guild of the fingers and toes. Different individuals may have
Cystic Fibrosis - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Cystic Fibrosis - Heat Map and Analysis to its growing collection of premium market research reports. Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body’s epithelial cells, and result in
Cystic Fibrosis - Heat Map And Analysis
MarketResearchReports.Biz is providing you Latest Market Research report of "Cystic Fibrosis - Heat Map And Analysis". Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body?s epithelial cells, and result in the buildup of a thick and sticky mucus in the lungs